The Law Firm Of Weiss & Lurie Investigates The Acquisition Of Gerber Scientific
Weiss & Lurie, a national class action and shareholder rights law firm
with offices in New York City and Los Angeles, is investigating possible
breaches of fiduciary duty and other violations of law by the Board of
Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Gerber Scientific, Inc. (NYSE: GRB), arising from its proposed acquisition by Vector Capital Corporation, a private equity firm. Under the proposed transaction, Gerber shareholders will receive $11 per share. In addition, each shareholder will receive for each share they own a non-transferable right to receive contingent cash payments at future times if recoveries are made pursuant to certain litigation claims in respect to U.S. Patent 5,537,135. The acquisition is expected to close later this year. Weiss & Lurie is investigating whether Gerber’s Board acted in the best interests of shareholders in approving the transaction and whether the Board properly sought to maximize shareholder value. For its fiscal third quarter 2011 ended January 31, 2011, Gerber reported net income of $1.7 million and a substantial 13% increase in revenue compared to its third quarter 2010. If you own Gerber shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Julia J. Sun either by email at email@example.com or by telephone at (888) 593-4771. Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (such as insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading press releases or SEC filings), consumer fraud (such as false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at firstname.lastname@example.org or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/. Attorney Advertising. Past results do not guarantee a similar outcome.
Gerber Scientific (NYSE:GRB) hit a new 52-week high Friday as it is currently trading at $11.18, above its previous 52-week high of $11.15 with 9,721 shares traded as of 10:16 a.m. ET. Average volume has been 492,800 shares over the past 30 days.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $10.87 as of 9:31 a.m. ET, 33.9% above Friday's closing price of $8.12. Volume is at 11.6 million, 217.1 times the daily average of 53,200.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $9.47 as of 9:56 a.m. ET, 20.9% above Wednesday's closing price of $7.83. Volume is at 27,319, 0.4 times the daily average of 61,900.